Japan's Taisho declines at home and overseas

4 February 2019 - Deborah Wilkes

Archived

Japan's Taisho Pharmaceutical has reported falling Self-Medication sales at home and overseas, as it prepares to acquire Bristol-Myers Squibb's French consumer healthcare business UPSA.

Click tags below for more information on topics:

Taisho

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: